Search Results - Tom Tidhar

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits by Nick Scott, Thin Mar Win, Tom Tidhar, Hla Htay, Bridget Draper, Phyo Thu Zar Aung, Yinzong Xiao, Anna Bowring, Christian Kuschel, Sonjelle Shilton, Khin Pyone Kyi, Win Naing, Khin Sanda Aung, Margaret Hellard

Connect to this object online.

Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study by Dr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, Prof Mark Stoove, Dr Rachel Sacks-Davis, A/Prof Joseph S. Doyle, Dr Alisa Pedrana, Prof Alexander J. Thompson, Prof David P. Wilson, Prof Margaret Hellard

Connect to this object online.

Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial by Katherine E Eddy, Joshua P Vogel, Nick Scott, Dagnachew Fetene, Tom Tidhar, Olufemi T Oladapo, Gilda Piaggio, My Huong Nguyen, Fernando Althabe, Rajiv Bahl, Suman P N Rao, Ayesha De Costa, Suchita Gupta, Abdullah H. Baqui, Mohammod Shahidullah, Saleha Begum Chowdhury, Salahuddin Ahmed, Saima Sultana, Iffat Ara Jaben, Shivaprasad S Goudar, Sangappa M Dhaded, Yeshita V Pujar, Sunil S Vernekar, Saraswati Welling, Geetanjali M Katageri, Muttappa R Gudadinni, Saumya Nanda, Zahida Qureshi, Harriet Tunu Baraka, Alfred Osoti, George Gwako, John Kinuthia, Samuel Ojo, Adesina Olubukola Adeponle, Ayede Adejumoke Idowu, Ebunoluwa Aderonke Adejuyigbe, Oluwafemi Kuti, Bankole Peter Kuti, Francis Bola Akinkunmi, Weyinmi Emmanuel Kubeyinje, Hadijat Olaide Raji, Olusanya Abiodun, Anthony Dennis Isah, Shabina Ariff, Sajid Bashir Soofi, Lumaan Sheikh, Almas Aamir, Farrukh Raza

Connect to this object online.